Crossmark

Novel Long-Acting Drug Combination Nanoparticles Composed of Gemcitabine and Paclitaxel Enhance Localization of Both Drugs in Metastatic Breast Cancer Nodules

Crossref DOI link: https://doi.org/10.1007/s11095-020-02888-8

Published Online: 2020-09-23

Published Print: 2020-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yu, Jesse

Mu, Qingxin

Perazzolo, Simone

Griffin, James I

Zhu, Linxi

McConnachie, Lisa A

Shen, Danny D

Ho, Rodney JY https://orcid.org/0000-0001-5960-4288
Funding

Funding for this research was provided by:

National Institute of Allergy and Infectious Diseases (AI120176)

National Institute of Allergy and Infectious Diseases (AI149665)

National Institute of Allergy and Infectious Diseases (AI1448055)

National Institute of General Medical Sciences (GM007750)
License Information

Text and Data Mining valid from 2020-09-23

Version of Record valid from 2020-09-23
More Information

Article History

Received: 28 April 2020

Accepted: 21 July 2020

First Online: 23 September 2020

Document is current

Any future updates will be listed below